A new study establishes that GLP-1 receptor agonists significantly reduce core behavioral markers of Binge Eating Disorder, including active binge episodes, loss-of-control eating, and emotional eating.
Trending
- Pennsylvania Gov. Josh Shapiro joins Morning Joe
- The White House is dictating access to frontier AI models, shifting power from tech giants, sources say
- Trump Casts Unfounded Doubts on US Elections
- New Jersey Governor Mikie Sherrill
- Luxury living in northern Vietnam
- Ranking the NFL’s top 5 head coaches: Lombardi Trophies matter at the top
- Bryson DeChambeau rules controversy sent The Open into chaos and absurdity
- A hair-brained NFL proposal to steal one thing from the World Cup format
